TY - JOUR
T1 - 脳神経疾患克服に向けた研究推進の提言2020，総論
AU - Future Vision Committee of Japanese Society of Neurology
AU - Mochizuki, Hideki
AU - Aoki, Masashi
AU - Ikenaka, Kensuke
AU - Inoue, Haruhisa
AU - Iwatsubo, Takeshi
AU - Ugawa, Yoshikazu
AU - Okazawa, Hitoshi
AU - Ono, Kenjiro
AU - Onodera, Osamu
AU - Kitagawa, Kazuo
AU - Saito, Yuko
AU - Shimohata, Takayoshi
AU - Takahashi, Ryosuke
AU - Toda, Tatsushi
AU - Nakahara, Jin
AU - Matsumoto, Riki
AU - Mizusawa, Hidehiro
AU - Mitsui, Jun
AU - Murayama, Shigeo
AU - Katsuno, Masahisa
AU - Aoki, Yoshitsugu
AU - Ishiura, Hiroyuki
AU - Izumi, Yuishin
AU - Koike, Haruki
AU - Shimada, Hitoshi
AU - Takahashi, Yuji
AU - Tokuda, Takahiko
AU - Nakajima, Hideto
AU - Hatano, Taku
AU - Misawa, Sonoko
AU - Watanabe, Hirohisa
N1 - Publisher Copyright:
© 2021 Societas Neurologica Japonica. All rights reserved.
PY - 2021
Y1 - 2021
N2 - The Japanese Society of Neurology discusses research, education, and medical care in the field of neurology and makes recommendations to the national government. Dr. Mizusawa, the former representative director of the Japanese Society of Neurology, selected committee members and made - Recommendations for Promotion of Research for Overcoming Neurological Diseases" in 2013. After that, the Future Vision Committee was established in 2014, and these recommendations have been revised once every few years by the committee. This time, the Future Vision Committee made the latest recommendations from 2020 to 2021. In this document, the general part is 1) What is neurological disease? 2) Current status of neurological disease overcoming research, 3) Significance and necessity of neurological disease overcoming research, 4) Research promotion system for overcoming neurological disease, 5) the roadmap for overcoming neuromuscular diseases, 6) a summary version of these recommendations are explained using figures that are easy for the general public to understand.
AB - The Japanese Society of Neurology discusses research, education, and medical care in the field of neurology and makes recommendations to the national government. Dr. Mizusawa, the former representative director of the Japanese Society of Neurology, selected committee members and made - Recommendations for Promotion of Research for Overcoming Neurological Diseases" in 2013. After that, the Future Vision Committee was established in 2014, and these recommendations have been revised once every few years by the committee. This time, the Future Vision Committee made the latest recommendations from 2020 to 2021. In this document, the general part is 1) What is neurological disease? 2) Current status of neurological disease overcoming research, 3) Significance and necessity of neurological disease overcoming research, 4) Research promotion system for overcoming neurological disease, 5) the roadmap for overcoming neuromuscular diseases, 6) a summary version of these recommendations are explained using figures that are easy for the general public to understand.
KW - General part
KW - Industry-Government-Academia collaboration
KW - Japanese Society of Neurology
KW - Recommendations from Japanese Society of Neurology
KW - Research for Overcoming Neurological Diseases
UR - http://www.scopus.com/inward/record.url?scp=85120376602&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85120376602&partnerID=8YFLogxK
U2 - 10.5692/clinicalneurol.cn-001639
DO - 10.5692/clinicalneurol.cn-001639
M3 - Article
C2 - 34657923
AN - SCOPUS:85120376602
SN - 0009-918X
VL - 61
SP - 709
EP - 721
JO - Clinical Neurology
JF - Clinical Neurology
IS - 11
ER -